rdf:type |
|
lifeskim:mentions |
umls-concept:C0008286,
umls-concept:C0031586,
umls-concept:C0040615,
umls-concept:C0205198,
umls-concept:C0205369,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C0597357,
umls-concept:C1552599,
umls-concept:C1704675,
umls-concept:C1704787
|
pubmed:issue |
2
|
pubmed:dateCreated |
1982-12-18
|
pubmed:abstractText |
Various antipsychotic and antidepressant drugs have been tested for their effects on the binding of [3H] phorbol-dibutyrate (PDBu) to its specific receptor. Chlorpromazine and related antipsychotic tricyclic compounds competitively inhibit the interaction between tumor-promoting phorbol esters and their specific receptors. The relative potency of drugs in competing for [3H]PDBU to receptors is fluphenzine greater than flupenthioxal greater than 2-chloroimipramine greater than chlorpromazine greater than imipramine. The significance of these findings is discussed with special reference to the potential tumor-promoting activity of these drugs.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents, Tricyclic,
http://linkedlifedata.com/resource/pubmed/chemical/Antipsychotic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Caenorhabditis elegans Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Chlorpromazine,
http://linkedlifedata.com/resource/pubmed/chemical/Phorbol Esters,
http://linkedlifedata.com/resource/pubmed/chemical/Phorbols,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Drug,
http://linkedlifedata.com/resource/pubmed/chemical/Unc-13 protein, C elegans,
http://linkedlifedata.com/resource/pubmed/chemical/phorbol ester receptor
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0304-3835
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
171-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6127156-Animals,
pubmed-meshheading:6127156-Antidepressive Agents, Tricyclic,
pubmed-meshheading:6127156-Antipsychotic Agents,
pubmed-meshheading:6127156-Brain,
pubmed-meshheading:6127156-Caenorhabditis elegans Proteins,
pubmed-meshheading:6127156-Cell Fractionation,
pubmed-meshheading:6127156-Chlorpromazine,
pubmed-meshheading:6127156-Dose-Response Relationship, Drug,
pubmed-meshheading:6127156-Drug Interactions,
pubmed-meshheading:6127156-Mice,
pubmed-meshheading:6127156-Phorbol Esters,
pubmed-meshheading:6127156-Phorbols,
pubmed-meshheading:6127156-Protein Kinase C,
pubmed-meshheading:6127156-Receptors, Drug
|
pubmed:articleTitle |
Chlorpromazine and related antipsychotic tricyclic compounds competitively inhibit the interaction between tumor-promoting phorbol esters and their specific receptors.
|
pubmed:publicationType |
Journal Article
|